Today’s guest post comes from Rob Brown, VP/GM of RxCrossroads by McKesson Program Pharmacy.
Rob reviews how COVID-19 is changing patient access and adherence to specialty therapies. He then describes specific RxCrossroads’ program changes that are helping patients and providers remain on therapy and navigate this challenging environment.
To learn more, visit www.McKesson.com/RxCrossroads.
Read on for Rob’s insights.
Read more »
Source: Post feed
